BioCentury
ARTICLE | Company News

Searle extends alliance with Myriad

January 20, 2000 8:00 AM UTC

Searle extended its relationship with MYGN to use its ProNet protein interaction technologies for drug target discovery and expanded the collaboration from two to three disease pathways. Under the ext...